Onyx Biotec IPO : Key Performance Indicators, PE Ratio, EPS, ROE, ROCE
For the Onyx Biotec IPO, the company is issuing shares at a pre-issue EPS of ₹2.54 and a post-issue EPS of ₹1.67. The pre-issue P/E ratio is 24.01x, while the post-issue P/E ratio is 36.52x against the Industry P/E ratio is 75.10x. The company's ROCE for FY24 is 10.58% and RoE for FY24 is 12.19%. These metrics suggest that the IPO is fairly priced.
Key Performance Indicator |
|||||||||||
| KPI | Values | ||||||||||
| EPS Pre IPO (Rs.) | ₹2.54 | ||||||||||
| EPS Post IPO (Rs.) | ₹1.67 | ||||||||||
| P/E Pre IPO | 24.01 | ||||||||||
| P/E Post IPO | 36.52 | ||||||||||
| ROE | 12.19% | ||||||||||
| ROCE | 10.58% | ||||||||||
| P/BV | 1.99 | ||||||||||
| Debt/Equity | 1.24 | ||||||||||
| RoNW | 12.19% | ||||||||||
Copyright @2020 Design & Developed by Info Web Software